This inventor holds 4 USPTO granted patents and 12 published patent applications and 2 EPO patents. Top assignees: University of California, Northwestern University. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2021-2025
Title: Innovations and Contributions of Iowis Zhu
Introduction
Iowis Zhu is a prominent inventor based in San Francisco, California. He has made significant contributions to the field of biotechnology, particularly in T cell therapeutics and transcriptional regulation. With a total of four patents to his name, Zhu's work is at the forefront of medical innovation.
Latest Patents
Zhu's latest patents include "Compositions and methods for enhancing adoptive T cell therapeutics." This patent focuses on improving T cell therapy through polypeptides and recombinant nucleic acid constructs that enhance T cell signaling and persistence in tumors. Another notable patent is "Receptors for ligand-dependent transcriptional regulation," which introduces a new class of receptors engineered to modulate transcriptional regulation without the need for previously essential Notch negative regulatory regions. These innovations have the potential to treat various health conditions, including cancers.
Career Highlights
Throughout his career, Iowis Zhu has worked with esteemed institutions such as the University of California and Northwestern University. His research has significantly advanced the understanding and application of T cell therapies, making him a key figure in the field.
Collaborations
Zhu has collaborated with notable colleagues, including Kole T Roybal and Raymond Liu. These partnerships have fostered a collaborative environment that enhances the impact of their research.
Conclusion
Iowis Zhu's contributions to biotechnology and his innovative patents highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in medical therapies and treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile